Latest Asx Listing Rules News

Veris Limited has announced the renewal of its on-market share buy-back program, aiming to repurchase up to 10% of its shares over the next year. This move reflects confidence in its financial position and current market conditions.

Raptis Group Limited has secured $16.6 million in revenue through two related party transactions, pending shareholder approval. These deals, facilitated by its subsidiary FSU Capital, highlight ongoing strategic partnerships within the company’s leadership circle.

Dragon Mountain Gold Limited has responded to an ASX price query following a sharp share price increase, denying any undisclosed information and confirming compliance with continuous disclosure rules.

Alara Resources Limited has addressed an ASX query regarding the late filing of a director's interest notice, attributing the delay to complexities in share ownership disclosure. The company confirms existing compliance arrangements remain robust.

The ASX has suspended the securities of Antilles Gold, Heramed, and Syntara due to missed periodic report deadlines, signaling compliance concerns ahead of potential reinstatement.

SIV Capital Limited reported a positive net cash flow for Q4 FY25 and holds $8.177 million in cash, while evaluating a new acquisition opportunity despite ongoing ASX suspension.

Xstate Resources has divested its Austrian Anshof project to concentrate on its upcoming Diona drilling campaign in Queensland and a planned ASX re-listing backed by a $2-3 million capital raise.

Admiralty Resources NL reported a cash balance of $1.738 million at the end of June 2025, supported by financing facilities that provide nearly seven quarters of operational funding. The company’s latest cash flow report reveals ongoing investment in exploration alongside careful management of its loan facilities.

PPK Group has dismissed any undisclosed information behind its recent share price surge, revealing instead that acquisition talks over its Craig International Ballistics stake have been terminated.

Botanix Pharmaceuticals confirms material sales and prescription growth data, explaining the timing of its ASX disclosures amid share price fluctuations.

MCS Services Limited reported a solid cash position and positive operating cash flow for the June 2025 quarter while advancing discussions on selling its Traffic Business subsidiary.

Hexima Limited reported a stable cash balance of AUD 1.54 million for Q2 2025, with only minor net cash used in operating activities. The company remains focused on strategic opportunities to enhance shareholder value.